Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations2016 · 610 citations
2. 2PD-1 Inhibitors Raise Survival in NSCLC2013 · 9 citations
3. 3Cutaneous melanoma2013 · 532 citations
4. 4Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines2023 · 35 citations
5. 5Role of Immunotherapy in Castration‐Resistant Prostate Cancer ( <scp>CRPC</scp> )2013 · 12 citations